Syringes Market (Product Type: General Purpose Syringe, Smart Syringes, and Specialized Syringes; Application: Therapeutics, Diagnostics, Immunization, and Others; Usage: Disposable and Reusable) - Europe Industry Analysis, Size, Share, Growth, Trends, an
Description
Syringes Market (Product Type: General Purpose Syringe, Smart Syringes, and Specialized Syringes; Application: Therapeutics, Diagnostics, Immunization, and Others; Usage: Disposable and Reusable) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Europe Syringes Market – Scope of Report
TMR’s report on the syringes market in Europe studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the syringes market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of syringes market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the syringes market in Europe.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the syringes market in Europe.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the syringes market in Europe. These serve as valuable tools for existing market players as well as for entities interested in participating in the syringes market in Europe.
The report delves into the competitive landscape of the syringes market. Key players operating in the syringes market in Europe have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the syringes market profiled in this report.
Research Methodology
The research methodology is a combination of exhaustive primary and secondary research to analyze the syringes market.
Secondary Research
Secondary research included a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we referred to include, but are not limited to:
Company websites, presentations, annual reports, white papers, technical papers, product brochures
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
Veterinary Council of Europe
Europen Federation of Animal Health
Animal Welfare Board of Europe
Company Information
Statista
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of the research, we conducted in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by extensive secondary research.
We conducted primary interviews with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who took part in the process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts
Key opinion leaders specializing in the market with respect to different industry verticals
Primary participants included, but are not limited to:
Bayer AG
Elanco Products Company
Merck & Co., Inc.
Ceva Sante Animale
Virbac SA
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter
Market Estimation: Market size estimations involved an in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we used modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Population, inflation rates, and others
Industry Indicators: Production data, R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived by taking into account drivers, restraints/challenges, opportunities prevailing in the market, and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise consumption data are the other pivotal factors considered to derive market forecasts.
Europe Syringes Market – Scope of Report
TMR’s report on the syringes market in Europe studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the syringes market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of syringes market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the syringes market in Europe.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the syringes market in Europe.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the syringes market in Europe. These serve as valuable tools for existing market players as well as for entities interested in participating in the syringes market in Europe.
The report delves into the competitive landscape of the syringes market. Key players operating in the syringes market in Europe have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the syringes market profiled in this report.
Research Methodology
The research methodology is a combination of exhaustive primary and secondary research to analyze the syringes market.
Secondary Research
Secondary research included a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we referred to include, but are not limited to:
Company websites, presentations, annual reports, white papers, technical papers, product brochures
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
Veterinary Council of Europe
Europen Federation of Animal Health
Animal Welfare Board of Europe
Company Information
Statista
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of the research, we conducted in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by extensive secondary research.
We conducted primary interviews with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who took part in the process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts
Key opinion leaders specializing in the market with respect to different industry verticals
Primary participants included, but are not limited to:
Bayer AG
Elanco Products Company
Merck & Co., Inc.
Ceva Sante Animale
Virbac SA
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter
Market Estimation: Market size estimations involved an in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we used modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Population, inflation rates, and others
Industry Indicators: Production data, R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived by taking into account drivers, restraints/challenges, opportunities prevailing in the market, and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise consumption data are the other pivotal factors considered to derive market forecasts.
Table of Contents
497 Pages
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary : Europe Syringes Market
- 4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Europe Syringes Market Analysis and Forecast, 2017–2031
- 4.4.1. Market Revenue Projections (US$ Mn)
- 5. Key Insights
- 5.1. List of Major Plastic Manufacturers
- 5.2. Pricing Analysis
- 5.3. Key Industry Events (Mergers, Acquisitions, Partnerships, etc.)
- 5.4. Covid-19 Impact Analysis
- 6. Europe Syringes Market Analysis and Forecast, by Product Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product Type, 2017–2031
- 6.3.1. General Purpose Syringes
- 6.3.2. Specialized Syringes
- 6.3.2.1. Insulin
- 6.3.2.2. Others
- 6.3.3. Smart Syringes
- 6.4. Market Attractiveness, by Product Type
- 7. Europe Syringes Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by End-user, 2017–2031
- 7.3.1. Hospitals & Clinics
- 7.3.2. Independent Diagnostics Laboratories
- 7.3.3. Blood Banks
- 7.3.4. Pharmaceuticals & Biotechnologies Companies
- 7.3.5. Veterinary Facilities
- 7.3.6. Others
- 7.4. Market Attractiveness, by End-user
- 8. Europe Syringes Market Analysis and Forecast, by Material
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value & Volume Forecast, by Material, 2017–2031
- 8.3.1. Plastic
- 8.3.1.1. PP
- 8.3.1.2. LDPE
- 8.3.1.3. HDPE
- 8.3.1.4. Others
- 8.3.2. Glass
- 8.4. Market Attractiveness, by Material
- 9. Europe Syringes Market Analysis and Forecast, by Application
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast, by Application, 2017–2031
- 9.3.1. Therapeutics
- 9.3.2. Diagnostics
- 9.3.3. Immunization
- 9.3.4. Others
- 9.4. Market Attractiveness, by Application
- 10. Europe Syringes Market Analysis and Forecast, by Usage
- 10.1. Introduction & Definition
- 10.2. Key Findings / Developments
- 10.3. Market Value Forecast, by Usage , 2017–2031
- 10.3.1. Disposable Syringes
- 10.3.1.1. Conventional Syringes
- 10.3.1.2. Safety Syringes
- 10.3.2. Reusable Syringes
- 10.4. Market Attractiveness, by Usage
- 11. Europe Syringes Market Analysis and Forecast, by Country/Sub-region
- 11.1. Key Findings
- 11.2. Market Value Forecast, by Country/Sub-region, 2017–2031
- 11.2.1. Germany (Section-12)
- 11.2.2. U.K. (Section-13)
- 11.2.3. France (Section-14)
- 11.2.4. Italy (Section-15)
- 11.2.5. Spain (Section-16)
- 11.2.6. Sweden (Section-17)
- 11.2.7. Portugal (Section-18)
- 11.2.8. Belgium (Section-19)
- 11.2.9. Netherlands (Section-20)
- 11.2.10. Switzerland (Section-21)
- 11.2.11. Austria (Section-22)
- 11.2.12. Russia (Section-23)
- 11.2.13. Poland (Section-24)
- 11.2.14. Baltics (Section-25)
- 11.2.15. Croatia (Section-26)
- 11.2.16. Czech Republic (Section-27)
- 11.2.17. Hungary (Section-28)
- 11.2.18. Romania (Section-29)
- 11.2.19. Slovakia (Section-30)
- 11.2.20. Slovenia (Section-31)
- 11.2.21. Ukraine (Section-32)
- 11.2.22. Rest of Europe (Section-33)
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Product Type
- 11.3.2. By End-user
- 11.3.3. By Material
- 11.3.4. By Application
- 11.3.5. By Usage
- 12. Competition Landscape (Section 26)
- 12.1. Market Player – Competition Matrix (By Tier and Size of companies)
- 12.2. Market Ranking Analysis By Company (2021)
- 12.3. Company Profiles
- 12.3.1. Baxter International Inc
- 12.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.1.2. Product Portfolio
- 12.3.1.3. SWOT Analysis
- 12.3.1.4. Strategic Overview
- 12.3.2. B. Braun Melsungen AG
- 12.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.2.2. Product Portfolio
- 12.3.2.3. SWOT Analysis
- 12.3.2.4. Strategic Overview
- 12.3.3. Becton, Dickinson and Company (BD)
- 12.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.3.2. Product Portfolio
- 12.3.3.3. SWOT Analysis
- 12.3.3.4. Strategic Overview
- 12.3.4. Cardinal Health
- 12.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.4.2. Product Portfolio
- 12.3.4.3. SWOT Analysis
- 12.3.4.4. Strategic Overview
- 12.3.5. Gerresheimer AG
- 12.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.5.2. Product Portfolio
- 12.3.5.3. SWOT Analysis
- 12.3.5.4. Strategic Overview
- 12.3.6. Medtronic plc
- 12.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.6.2. Product Portfolio
- 12.3.6.3. SWOT Analysis
- 12.3.6.4. Strategic Overview
- 12.3.7. Nipro Corporation
- 12.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.7.2. Product Portfolio
- 12.3.7.3. SWOT Analysis
- 12.3.7.4. Strategic Overview
- 12.3.8. Gerresheimer AG
- 12.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.8.2. Product Portfolio
- 12.3.8.3. SWOT Analysis
- 12.3.8.4. Strategic Overview
- 12.3.9. SCHOTT AG
- 12.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.9.2. Product Portfolio
- 12.3.9.3. SWOT Analysis
- 12.3.9.4. Strategic Overview
- 12.3.10. ICU Medical Inc
- 12.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.10.2. Product Portfolio
- 12.3.10.3. SWOT Analysis
- 12.3.10.4. Strategic Overview
- 12.3.11. Terumo Corporation
- 12.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.11.2. Product Portfolio
- 12.3.11.3. SWOT Analysis
- 12.3.11.4. Strategic Overview
- 12.3.12. Teleflex Incorporated
- 12.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.12.2. Product Portfolio
- 12.3.12.3. SWOT Analysis
- 12.3.12.4. Strategic Overview
- 12.3.13. Vitrex Medical A/S (CTI Group)
- 12.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 12.3.13.2. Product Portfolio
- 12.3.13.3. SWOT Analysis
- 12.3.13.4. Strategic Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
